NxStage Medical, Inc. (NXTM) financial statements (2022 and earlier)
Company profile
| Business Address |
350 MERRIMACK STREET LAWRENCE, MA 01843 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 65 | 60 | 59 | 53 | 84 | 106 | ||
| Cash and cash equivalents | 65 | 60 | 59 | 53 | 84 | 106 | ||
| Receivables | 32 | 32 | 25 | 24 | 20 | 19 | ||
| Inventory, net of allowances, customer advances and progress billings | 49 | 47 | 38 | 45 | 38 | 34 | ||
| Inventory | 49 | 47 | 38 | 45 | 38 | 34 | ||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | ✕ | 3 | ||
| Other undisclosed current assets | 8 | 6 | 6 | 7 | 4 | |||
| Total current assets: | 153 | 145 | 129 | 129 | 146 | 161 | ||
| Noncurrent Assets | ||||||||
| Property, plant and equipment | 60 | 62 | 67 | 67 | 52 | 36 | ||
| Intangible assets, net (including goodwill) | 50 | 52 | 54 | 56 | 59 | 62 | ||
| Goodwill | 43 | 43 | 43 | 42 | 42 | 42 | ||
| Intangible assets, net (excluding goodwill) | 8 | 10 | 12 | 14 | 17 | 20 | ||
| Deferred costs | 31 | 33 | 33 | 34 | 35 | 38 | ||
| Other noncurrent assets | 6 | 3 | 3 | 3 | 2 | ✕ | ||
| Prepaid expense and other noncurrent assets | ✕ | ✕ | ✕ | ✕ | ✕ | 4 | ||
| Other undisclosed noncurrent assets | 24 | 22 | 21 | 21 | 13 | 10 | ||
| Total noncurrent assets: | 172 | 172 | 178 | 181 | 161 | 150 | ||
| TOTAL ASSETS: | 326 | 317 | 307 | 310 | 307 | 312 | ||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities | 43 | 45 | 38 | 51 | 46 | 48 | ||
| Accounts payable | 15 | 14 | 11 | 14 | 15 | 17 | ||
| Accrued liabilities | 28 | 31 | 27 | 25 | 21 | 20 | ||
| Employee-related liabilities | 12 | 9 | 8 | |||||
| Taxes payable | 1 | 2 | ||||||
| Debt | 0 | 0 | 0 | 2 | 0 | |||
| Deferred revenue and credits | 2 | |||||||
| Other liabilities | 5 | 4 | 4 | 6 | 2 | 2 | ||
| Other undisclosed current liabilities | (17) | (10) | (11) | |||||
| Total current liabilities: | 47 | 49 | 43 | 45 | 38 | 39 | ||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation | 1 | 1 | 2 | 13 | 1 | |||
| Long-term debt, excluding current maturities | 1 | 1 | 2 | 1 | 1 | |||
| Capital lease obligations | 12 | |||||||
| Liabilities, other than long-term debt | 65 | 65 | 69 | 73 | 75 | 77 | ||
| Deferred revenue and credits | 47 | 49 | 51 | 53 | 53 | 59 | ||
| Postemployment benefits liability | ✕ | ✕ | ✕ | ✕ | 2 | 2 | ||
| Other liabilities | 18 | 16 | 17 | 20 | 20 | 16 | ||
| Other undisclosed noncurrent liabilities | (12) | (2) | (2) | |||||
| Total noncurrent liabilities: | 65 | 66 | 70 | 73 | 75 | 75 | ||
| Total liabilities: | 113 | 115 | 113 | 118 | 112 | 114 | ||
| Temporary equity, carrying amount | (0) | 0 | 0 | |||||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent | 213 | 201 | 192 | 190 | 194 | 198 | ||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Treasury stock, value | (19) | (16) | (14) | (13) | (10) | (10) | ||
| Additional paid in capital | 658 | 631 | 612 | 593 | 567 | 552 | ||
| Accumulated other comprehensive income (loss) | (4) | (6) | (4) | (2) | 0 | 0 | ||
| Accumulated deficit | (422) | (408) | (403) | (387) | (364) | (345) | ||
| Stockholders' equity attributable to noncontrolling interest | (0) | 1 | 2 | 1 | 1 | |||
| Total stockholders' equity: | 213 | 202 | 194 | 192 | 195 | 198 | ||
| Other undisclosed liabilities and equity | (0) | |||||||
| TOTAL LIABILITIES AND EQUITY: | 326 | 317 | 307 | 310 | 307 | 312 | ||
Income statement (P&L) ($ in millions)
| 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 394 | 366 | 336 | 302 | 268 | 246 | |
| Revenue, net | 394 | 366 | 336 | 306 | 268 | 246 | |
| Cost of revenue (Cost of Goods and Services Sold) | (226) | (214) | (205) | (212) | (161) | (149) | |
| Other undisclosed gross profit | 26 | (4) | (4) | ||||
| Gross profit: | 168 | 152 | 131 | 116 | 103 | 93 | |
| Operating expenses | (182) | (156) | (146) | (138) | (120) | (104) | |
| Operating loss: | (14) | (4) | (15) | (22) | (18) | (11) | |
| Nonoperating expense | (2) | (2) | (1) | (1) | (1) | (3) | |
| Other nonoperating income (expense) | (1) | (1) | 1 | (0) | (0) | (0) | |
| Interest and debt expense | (1) | (3) | |||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 1 | 3 | |||||
| Loss from continuing operations before income taxes: | (15) | (6) | (15) | (23) | (19) | (14) | |
| Income tax expense (benefit) | 0 | (1) | (1) | (1) | 0 | (1) | |
| Net loss: | (15) | (7) | (16) | (24) | (19) | (15) | |
| Net income (loss) attributable to noncontrolling interest | 1 | 3 | 1 | (0) | |||
| Other undisclosed net income attributable to parent | 1 | ||||||
| Net loss attributable to parent: | (14) | (5) | (15) | (24) | (19) | (15) | |
| Preferred stock dividends and other adjustments | (0) | ||||||
| Net loss available to common stockholders, diluted: | (14) | (5) | (15) | (24) | (19) | (15) | |
Comprehensive Income ($ in millions)
| 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|---|
| Net loss: | (15) | (7) | (16) | (24) | (19) | (15) | |
| Other comprehensive income (loss) | 2 | (2) | (2) | (2) | (0) | 1 | |
| Comprehensive loss: | (13) | (9) | (18) | (27) | (19) | (15) | |
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 1 | 3 | 1 | (0) | |||
| Other undisclosed comprehensive income, net of tax, attributable to parent | 1 | ||||||
| Comprehensive loss, net of tax, attributable to parent: | (12) | (7) | (17) | (26) | (19) | (15) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.